Relating to post-market surveys conducted by Guidant

Boston Scientific has entered into a civil settlement with the US Department of Justice regarding the department’s investigation relating to certain post-market surveys conducted by Guidant, before Boston Scientific acquired it in 2006. The company had previously disclosed the investigation, which was conducted by the US Attorney’s office in Boston.

This civil settlement brings to a conclusion to an investigation that began in 2005 and involves no admission of wrong doing by the company. Under the terms of the settlement, the company has agreed to pay $22m, which was previously fully accrued, said the company.

The company also agreed to enter into a Corporate Integrity Agreement (CIA) with the Office of Inspector General for the US Department of Health and Human Services. The CIA requires enhancements to certain compliance procedures related to financial arrangements with health care providers. It is limited to the company’s cardiac rhythm management business, which became part of Boston Scientific through the Guidant acquisition.